Glaucoma News and Research RSS Feed - Glaucoma News and Research

While there are many causes of glaucoma, most cases are associated with increased intraocular pressure. Loss of vision is usually characterized by a gradual reduction in peripheral vision, which can lead to a tunnel vision effect. Glaucoma affects approximately 100 million people globally and is one of the leading causes of blindness in the world today. An estimated three million Americans have this sight-threatening disease. Because it is painless and advances gradually, many people who have glaucoma or elevated IOP have not been diagnosed. If detected and treated early, vision can usually be preserved.
Researchers receive grant to help develop stem cell therapy for glaucoma

Researchers receive grant to help develop stem cell therapy for glaucoma

Researchers from the University's Institute of Ageing and Chronic Disease have been awarded a pump-priming grant to help develop a stem cell therapy for glaucoma. [More]
Article provides insights into nutrient-rich foods that can help prevent glaucoma

Article provides insights into nutrient-rich foods that can help prevent glaucoma

In general, I recommend that my patients include nutrient-rich foods such as fruits and vegetables as part of a healthy diet. [More]
McMaster researchers develop better way to deliver medicine to surface of the eye

McMaster researchers develop better way to deliver medicine to surface of the eye

It's a problem as old and as aggravating as eye drops themselves: as soon as the medicine goes in, almost all of it washes right back out again. [More]
Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina. [More]
Novel drug-dispensing contact lens effective in providing better pressure reduction in glaucoma model

Novel drug-dispensing contact lens effective in providing better pressure reduction in glaucoma model

A contact lens designed to deliver medication gradually to the eye could improve outcomes for patients with conditions requiring treatment with eye drops, which are often imprecise and difficult to self-administer. [More]
RPB continues research initiative to address urgent needs in treating low vision

RPB continues research initiative to address urgent needs in treating low vision

Research to Prevent Blindness is continuing its research initiative to address urgent needs in understanding and treating low vision. [More]
Second annual USC VR Hackathon for international coders, designers focuses on Medical Empathy Machine

Second annual USC VR Hackathon for international coders, designers focuses on Medical Empathy Machine

Kicking off its second annual virtual reality (VR) Hackathon, the University of Southern California Center for Body Computing announced this year's focus of the competition is "Medical Empathy Machine," showcasing the potential of VR to change medicine and patient experience through emotion, compassion and empathy. [More]
Scientists use Regeneration Intelligence to assess perturbation status of many signaling pathways

Scientists use Regeneration Intelligence to assess perturbation status of many signaling pathways

Insilico Medicine, Inc in collaboration with scientists from Atlas Regeneration, Inc, Vision Genomics, Inc and Howard University published two research papers on fibrosis in the lung and liver and fibrotic signatures in glaucoma. [More]
USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant

USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant

Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007. [More]
Article sheds light on driving problems for glaucoma patients

Article sheds light on driving problems for glaucoma patients

Concerns about driving often come up with glaucoma and may be brought to the doctor's attention by the patient or a family member. Common complaints include glare, poor night vision and decreased contrast sensitivity. [More]
Mice study shows stem cell infusion could help treat glaucoma

Mice study shows stem cell infusion could help treat glaucoma

An infusion of stem cells could help restore proper drainage for fluid-clogged eyes at risk for glaucoma. That's the upshot of a study led by a Veterans Affairs and University of Iowa team. [More]
Scientists measure eye pressure of sleeping patients to find link between OSAS and glaucoma

Scientists measure eye pressure of sleeping patients to find link between OSAS and glaucoma

Scientists at Hokkaido University have successfully measured the eye pressure of sleeping patients with obstructive sleep apnea syndrome for the first time, finding an unexpected correlation with glaucoma. [More]
New, minimally invasive procedure may be effective for patients with FED

New, minimally invasive procedure may be effective for patients with FED

A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant. [More]
New eye test could help detect glaucoma earlier than current techniques

New eye test could help detect glaucoma earlier than current techniques

UNSW Australia scientists have developed a testing protocol that identifies the blinding eye disease glaucoma four years earlier than current techniques. [More]
Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients. [More]
Scientists succeed in restoring multiple key aspects of vision in mice

Scientists succeed in restoring multiple key aspects of vision in mice

Experiments conducted under the leadership of a Stanford University School of Medicine investigator have succeeded, for the first time, in restoring multiple key aspects of vision in mammals. [More]
Medical marijuana reduces use of prescription drugs, research finds

Medical marijuana reduces use of prescription drugs, research finds

Medical marijuana is having a positive impact on the bottom line of Medicare's prescription drug benefit program in states that have legalized its use for medicinal purposes, according to University of Georgia researchers in a study published today in the July issue of Health Affairs. [More]
Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses. [More]
TKCI Srujana Innovation Award launched to combat corneal blindness

TKCI Srujana Innovation Award launched to combat corneal blindness

The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop’ at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India. [More]
SeeAbility calls for free eye tests for people with learning disabilities in England

SeeAbility calls for free eye tests for people with learning disabilities in England

In a report launched in parliament tomorrow (Tuesday 5th July) national disability charity SeeAbility will say NHS England’s national sight testing and funding system is letting down the one million people with learning disabilities in England. [More]
Advertisement
Advertisement